Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (PTHS) Institutional Ownership

13F Institutional Holders and Ownership History for Q3 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
PTHS on NYSE
Shares outstanding
3,076,923
Price per share
$27.20
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
462,762
Total reported value
$12,957,336
% of total 13F portfolios
0%
Share change
+462,762
Value change
+$12,957,336
Number of holders
14
Price from insider filings
$27.20
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (PTHS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LIGAND PHARMACEUTICALS INC 50% 0% $175,394,186 +$8,832,244 5,189,177 +5.3% Ligand Pharmaceuticals Incorporated 06 Nov 2025
3i, LP 9.9% 303,138 3i, LP 01 Jul 2025
Murchinson Ltd. 9.1% $9,464,000 280,000 Murchinson Ltd. 30 Sep 2025
Friedberg Ezra M 8.3% 250,121 Ezra Friedberg 01 Jul 2025
Ikarian Capital, LLC 6.1% $6,300,590 186,408 Ikarian Capital, LLC 30 Sep 2025

As of 30 Sep 2025, 14 institutional investors reported holding 462,762 shares of Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (PTHS). This represents 15% of the company’s total 3,076,923 outstanding shares.

Top 14 Institutional Shareholders

The largest institutional shareholders of Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (PTHS) together control 15% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Murchinson Ltd. 9.1% 280,000 1.5% $7,840,000
VANGUARD GROUP INC 2.2% 66,836 0% $1,871,408
Ikarian Capital, LLC 2% 62,451 0.4% $1,748,628
BOOTHBAY FUND MANAGEMENT, LLC 0.69% 21,245 0.02% $594,860
DIADEMA PARTNERS LP 0.34% 10,498 0.2% $293,944
GEODE CAPITAL MANAGEMENT, LLC 0.34% 10,330 0% $289,240
Knott David M Jr 0.2% 6,112 0.07% $171,136
Persistent Asset Partners Ltd 0.08% 2,403 0.05% $67,284
Steward Partners Investment Advisory, LLC 0.06% 1,910 0% $53,480
Tower Research Capital LLC (TRC) 0.03% 827 0% $23,156
UBS Group AG 0% 137 0% $3,836
BANK OF AMERICA CORP /DE/ 0% 11 0% $308
CITIGROUP INC 0% 1 0% $28
JPMORGAN CHASE & CO 0% 1 0% $28

Institutional Holders of Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (PTHS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 462,762 $12,957,336 +$12,957,336 $28.00 14